Cannvas MedTech (CSE:MTEC), a leading digital cannabis educator and business technology company, and Advica Health, an innovative healthcare navigation service allowing members to access an independent appraisal of their health needs and circumstances, are pleased to announce the signing of a definitive contract whereby Cannvas.Me will be the exclusive provider of cannabis education and information to the Advica Health community.

“Advica Health is at the forefront of delivering medical treatment efficiently on a membership basis and we are very pleased to become their exclusive provider of physician-backed cannabis education,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “The need to educate Canadians about cannabis and its potential health benefits has never been greater and Cannvas.Me is an ideal learning tool for patients looking to take better control of their own health and wellness through organizations like Advica Health who have their patient’s best interests at heart. We believe that with a dedicated cannabis education section on the Advica portal where patients and health care professionals will be able to access evidence-based education and information about cannabis, Advica members will be better positioned to make informed decisions about their health treatments.”


Advica Health offers members access to the best facilities at home or abroad and assists in obtaining advice, treatment options and solutions to current health care situations in the most efficient manner possible. Each case is approached on an individual and personalized basis to help navigate the healthcare system and collaboratively create an effective health plan with ongoing care management and support from nurse navigators. Advica is constantly bringing innovative healthcare solutions to its membership with a strong focus on preventative health and wellness, and helps members focus on healthy living to positively impact their overall productivity and quality of life.

Cannvas.Me is an unbiased educational resource for medicinal and adult-use cannabis users. It operates independent of any licenced producers or clinics, working with its own Medical Advisory Board and Educational Advisory Panel to provide a safe space for cannabis education with no pressure to purchase or consume. Once fully integrated with the Advica Health website, Advica will refer patients to an online portal to access Cannvas.Me content; patients visiting participating medical clinics or related facilities will be able to access application-specific handheld devices providing content around the potential health benefits of cannabis.

“This is wonderful news for the Advica Health community, all of whom will soon be able to expand their cannabis knowledge with our physician-backed and educator-approved learning modules exploring everything about cannabis, including its health and wellness applications, its history and cultural impact and current research into the future of cannabis,” said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. “Further to their mission to simplify navigating the healthcare system for its members, Advica is helping destigmatize medicinal cannabis usage by providing its community with unbiased cannabis education through the Cannvas.Me platform to empower them to make better decisions about their own well-being.”

Cannvas.Me will have the entirety of its platform accessible to Advica Health members, and will work closely with Advica’s network of leading clinics, doctors and specialists, caregivers and home support to source information and collaborate on articles and learning modules to meet the needs of Advica members across Canada.

About Advica Health
Advica is dedicated to support Canadians who want to personalize their individual medical treatment. Advica acts as thoughtful advisors to assist patients to improve health and wellness. For additional information about Advica Health, visit advicahealth.com.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
CannvasMedTech.com
AdvicaHealth.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

For further information: Investor Relations: Renmark Financial Communications Inc., Shushu Feng: sfeng@renmarkfinancial.com, Tel: (416) 644-2020 or (212) 812-7680

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation. 

Source: www.newswire.ca

Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.

Keep reading... Show less

Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).

Keep reading... Show less

Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.

Keep reading... Show less

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less